Drug Therapy for Alcohol Dependence in Alaska Natives (Naltrexone/Sertraline)

Completed · Phase 2

Conditions studied: Alcoholism, Alcohol Dependence

In brief

This study will assess the ability of naltrexone (Revia) to reduce the risk of relapse in Alaska natives with alcohol dependence. The study will also examine whether a combination of naltrexone and sertraline (Zoloft) yields better abstinence rates than naltrexone used alone. Alaska Native individuals will be recruited into a 16 week outpatient study.

Key facts

Study ID
NCT00000451
Run by
Yale University
People needed
198
Starts
2003-01-01
Expected to finish
2005-11-01
Last updated by the study team
2013-01-29

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.